Julie Krop

Insider

First SEC filing: June 12, 2026 · Latest: June 12, 2026

On this page

Insider at

0 buys (P) 1 sells (S) Net: $-125,500 + 10 non-open-market transactions below last 12 months, based on the transactions shown below

Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted

10 other filings hidden

Date	Ticker	Code	Shares	Price	Value	Owned after	Δ own	A/D	vs now
June 23, 2026	AQST	M 10b5-1	25,000	—	—	0 Direct	-100.00%	Disposed	(price as of 2026-08-20)
June 23, 2026	AQST	S 10b5-1	25,000	$5.02	$125,500	0 Direct	-100.00%	Disposed	-9.4% (price as of 2026-08-20)
June 23, 2026	AQST	M 10b5-1	25,000	$0.71	$17,750	25,000 Direct	—	Acquired	540.8% (price as of 2026-08-20)
June 10, 2026	AQST	A	50,500	—	—	50,500 Direct	—	Acquired	(price as of 2026-08-20)
June 1, 2026	DMAC	A	67,500	—	—	67,500 Direct	—	Acquired	(price as of 2026-08-20)
June 11, 2025	AQST	A	42,000	$3.41	$143,220	42,000 Direct	—	Acquired	33.4% (price as of 2026-08-20)
June 20, 2024	AQST	A	38,000	—	—	38,000 Direct	—	Acquired	(price as of 2026-08-20)
June 21, 2023	AQST	A	25,000	—	—	25,000 Direct	—	Acquired	(price as of 2026-08-20)
June 22, 2022	AQST	A	25,000	—	—	25,000 Direct	—	Acquired	(price as of 2026-08-20)
June 15, 2021	AQST	A	20,000	—	—	20,000 Direct	—	Acquired	(price as of 2026-08-20)
March 11, 2021	AQST	A	28,500	—	—	28,500 Direct	—	Acquired	(price as of 2026-08-20)

P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding

Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.

Options, RSUs and convertible securities reported on Form 4 Table II.

Date	Ticker	Security	Underlying	Exercise price	Expiration	Shares	A/D
June 23, 2026	AQST	Non-Qualified Stock Option (right to buy)	Common Stock (25,000)	$0.71	June 22, 2032	25,000	Disposed
June 10, 2026	AQST	Stock Option (Right to Purchase)	Common Stock (50,500)	$3.99	June 10, 2036	50,500	Acquired
June 1, 2026	DMAC	Stock Option (right to buy)	Voting Common Shares (67,500)	$5.84	June 1, 2036	67,500	Acquired
June 11, 2025	AQST	Stock Option (Right to Purchase)	Common Stock (42,000)	$3.41	June 11, 2035	42,000	Acquired
June 20, 2024	AQST	Stock Option (Right to Purchase)	Common Stock (38,000)	$2.50	June 20, 2034	38,000	Acquired
June 21, 2023	AQST	Stock Option (Right to Purchase)	Common Stock (25,000)	$2.02	June 21, 2033	25,000	Acquired
June 22, 2022	AQST	Stock Option (Right to Purchase)	Common Stock (25,000)	$0.71	June 22, 2032	25,000	Acquired
June 15, 2021	AQST	Stock Option (Right to Purchase)	Common Stock (20,000)	$4.04	June 15, 2031	20,000	Acquired
March 11, 2021	AQST	Non-Qualified Stock Option (right to buy)	Common Stock (28,500)	$5.30	March 11, 2031	28,500	Acquired

Exercise/conversion price is blank when not applicable (e.g. RSUs).

Matched by name from proxy statements (DEF 14A) — verify against the filing.

M.D.(d)Chief Medical Officer

Fiscal year	Salary	Bonus	Stock awards	Option awards	Non-equity incentive	Pension change	Other	Total
2025	$198,980	—	—	$1,421,100	$79,592	—	$7,891	$1,707,563

Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.